• Microbiology, Immunology & Infectious Diseases

  • Events 

    Friday, April 25, 2014 | 8:00 AM - 5:30 PM

    Malaria 2014: Advances in Pathophysiology, Biology and Drug Development

    Keynote Speakers: Jane M. Carlton (New York University), Rick M. Fairhurst (National Institute of Allergy and Infectious Disease, NIH), Terrie E. Taylor (Michigan State University)
    Speakers: Myles Akabas (Albert Einstein College of Medicine), Purnima Bhanot (UMDNJ - New Jersey Medical School), Liwang Cui (Pennsylvania State University), Mahalia S. Desruisseaux (Albert Einstein College of Medicine), Miriam K. Laufer (University of Maryland School of Medicine), Laura Kirkman (Weill Cornell Medical College), Marcus Lee (Columbia University), Alexander Ploss (Princeton University), Photini Sinnis (Johns Hopkins University)

    Despite a 25% reduction in global malaria mortality since 2000, around half the world's population is at risk. Join us on World Malaria Day to examine breakthroughs in pathophysiology, pre-erythrocytic and liver stage biology, and drug development.

    Monday, May 5, 2014 | 7:30 AM - 3:00 PM

    HIV 2014: Science, Community and Policy for Key Vulnerable Populations

    Speakers: Fareed Abdullah (South African National AIDS Council, Pretoria, South Africa), Frederick Altice (Yale School of Medicine, New Haven, CT, USA), Joe Amon (Human Rights Watch, New York, NY, USA), Chasity Andrews (Aaron Diamond AIDS Research Center, New York, NY, USA), Chris Beyrer (Johns Hopkins Bloomberg School of Public Health, Baltimore, PA, USA), Frances Cowan (Centre for Sexual Health and HIV/AIDS Research Zimbabwe, Zimbabwe), Anna-Louise Crago (University of Toronto, Canada), Steven Deeks (University of California - San Francisco, CA, USA), Jerome Kim (Walter Reed Army Institute of Research, Bethesda, MD, USA), Luiz Loures (UNAIDS, Geneva, Switzerland), Kristen Marks (Weill Cornell Medical College, New York, NY, USA), Daniel Raymond (Harm Reduction Coalition, New York, NY, USA), Pavlo Smyrnov (International HIV/AIDS Alliance in Ukraine, Ukraine)

    The UNAIDS' vision of zero new HIV infections, zero AIDS-related deaths and zero discrimination provides a clear path for HIV research and policy. This symposium convenes clinicians, scientists, activists and policy-makers with the shared goal of improving outcomes for HIV in key vulnerable populations.

    Tuesday, May 20, 2014 | 8:00 AM - 5:00 PM

    Hot Technologies for Developing Next-Gen Biologics

    Speakers: Timothy Charlebois (Pfizer), David King (AnaptysBio Inc.), William M. Pardridge (Brain Research Institute, UCLA), Steven J. Projan (MedImmune), Sachdev Siddhu (University of Toronto), E. Sally Ward (UT Southwestern), Patrick C. Wilson (The University of Chicago), K. Dane Wittrup (Massachusetts Institute of Technology)

    New technologies are pivotal in developing next-generation biologics. This symposium highlights novel technologies in the discovery of new biologics, elucidating in vivo mechanisms of therapeutic proteins, and manufacturing and delivery processes.

    Monday, June 9, 2014 | 10:00 AM - 3:15 PM

    2014 Ross Prize in Molecular Medicine: Advances in Immunomodulation

    Featured Speakers: John J. O'Shea (National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH), James P. Allison (The University of Texas MD Anderson Cancer Center), Louis M. Staudt (National Cancer Institute, National Institutes of Health), Charles A. Dinarello (University of Colorado at Denver)

    This symposium will honor Dr. John O'Shea, the recipient of the 2014 Ross Prize in Molecular Medicine, in recognition of his discoveries in immunology and cytokine biology.

    Thursday, June 26, 2014 | 7:45 AM - 5:45 PM

    Demyelination and Remyelination: From Mechanism to Therapy

    Speakers: Douglas Arnold (McGill University), Diego Cadavid (Biogen Idec), Patrizia Casaccia (Mount Sinai School of Medicine), Jonah Chan (University of California, San Francisco), Andrew Eisen (Acorda Therapeutics), Charles ffrench-Constant (MRC Centre for Regenerative Medicine, University of Edinburgh), Vittorio Gallo (Children's National Medical Center and George Washington University), Steven Goldman (University of Rochester Medical Center), Catherine Lubetzki (Pierre and Marie Curie University), Wendy B. Macklin (University of Colorado School of Medicine), David Rowitch (University of California, San Francisco), Bruno Stankoff (Pierre and Marie Curie University)

    This translational conference will highlight biological and clinical findings in myelin development, new techniques for brain imaging and for screening molecular targets, and novel therapeutics that promote remyelination.

  • Past Events

    Tuesday, March 25, 2014 | 12:00 PM - 4:00 PM

    Lung Cancer: Advances in Current Treatment Modalities and Patient Classification

    Speakers: Rolf Brekken (UT Southwestern), Jessica S. Donington (NYU Langone Medical Center), Balazs Halmos (Columbia University Medical Center), Roy S. Herbst (Yale School of Medicine), Suresh S. Ramalingam (Emory University)

    Recent treatment advances may improve lung cancer patient survival rates, as understanding genetic heterogeneity can improve trial patient selection. Hear updates on common mutations, intraoperative chemotherapy, and insights from clinical trials.

    Monday, March 24, 2014 | 8:00 AM - 5:00 PM

    World TB Day Symposium: Countdown to 2015

    Speakers: David Alland (Rutgers New Jersey Medical School), Stephanie Boisson-Dupuis (The Rockefeller University), Andrea M. Cooper (Trudeau Institute), Jerrold J. Ellner (Boston Medical Center), Daniel E. Everitt (TB Alliance), Michael S. Glickman (Memorial Sloan-Kettering Cancer Center), Kathleen A. McDonough (Wadsworth Center ), Steven A. Porcelli (Albert Einstein College of Medicine), Kyu Rhee (Weill Cornell Medical College), G. Marcela Rodriguez (Rutgers New Jersey Medical School), Padmini Salgame (Rutgers New Jersey Medical School), Marie Samanovic (NYU Langone Medical Center), Jessica C. Seeliger (Stony Brook University)

    TB is a curable infection that should be a disease of the past, yet a third of the world's population remains affected. Join us on World TB Day to explore scientific insights towards novel diagnostics, therapeutics and vaccine-related tools.

    Tuesday, February 18, 2014 | 8:30 AM - 4:30 PM

    Strategies to Inhibit Graft-Versus-Host Disease While Sparing the Graft-Versus-Tumor Response: Finding the Sweet Spot

    Speakers: John DiPersio (Washington University School of Medicine), William R. Drobyski (Medical College of Wisconsin), James Ferrara (University of Michigan), David L. Porter, MD, University of Pennsylvania Medical Center, Robert J. Soiffer (Dana-Farber Cancer Institute), Megan Sykes (Columbia University), Marcel RM van den Brink (Memorial Sloan Kettering Cancer Center)

    Mechanisms that cause graft-versus-host disease (GvHD), a major cause of mortality after stem cell transplants, must be inhibited while preserving the graft-versus-tumor (GvT) response. Explore recent advances in separating GvHD from GvT effects.

    Monday, December 2, 2013 | 7:00 PM - 8:30 PM

    Hats Off to Bacteria!

    Speakers: Lawrence Brandt (Albert Einstein College of Medicine), Martin Blaser (New York University Medical Center), Maria Gloria Dominguez-Bello (New York University)

    Join us to learn about our basic microbial ecology; how our gut bacteria are linked to diabetes and obesity; how newborns are first colonized by bacteria; and how treatments are changing people's lives one single-celled organism at a time.

  • Publications 


    Dendritic Cell Therapies for Cancer: Biotech's Bumpy Road to the Market

    Organizers: John E. Hambor (Boehringer-Ingelheim Pharmaceuticals) and Jennifer Henry (The New York Academy of Sciences)

    Dendritic cells offer promise in the development of cancer vaccines.


    Hats Off to Bacteria!

    Moderator: Christine Gorman (Scientific American)
    Speakers: Martin Blaser (New York University), Lawrence Brandt (Albert Einstein College of Medicine), and Maria Gloria Dominguez-Bello (New York University)

    A panel discussed the impact on health care of new knowledge about human microbial ecology, highlighting the role bacteria play in childbirth, in diseases such as diabetes and obesity, and in general health and wellness.


    Unlocking the Secret of Global Health Victories

    Moderator: Ko-Yung Tung (Morrison & Foerster LLP)
    Featuring: Kiyoshi Kurokawa (GHIT Fund), Peter Piot (London School of Hygiene & Tropical Medicine, UK), B.T. Slingsby (GHIT Fund), Mel Spigelman (Global Alliance for TB Drug Development), and Ann M. Veneman (formerly of UNICEF)

    Experts discussed recent successes and setbacks in global health.


    The Microbiome in Health, Disease, and Therapeutics: Bugs, Guts, and Drugs

    Organizers: Mercedes Beyna (Pfizer), Robert Martone (Covance Biomarker Center of Excellence), Nilufer Seth (Pfizer), Richard Snyder (Covance Biomarker Center of Excellence), and Jennifer Henry (The New York Academy of Sciences)

    This eBriefing looks at how symbioses between humans and the gut microbiome impact drug metabolism, development, and a variety of disease states.

  • Podcasts

    April 2, 2010

    More than a Yogurt Cup

    Delve into the world of prebiotic and probiotic science. We talk to three people in the field and learn why keeping the good microbes in our bodies happy means a lot for health.

    Download (14 MB, 00:21:21)
  • Webinar Archives

    Webinar Archive
    March 2, 2010

    Emerging Infectious Diseases in Response to Climate Change

    Climate and weather are important components of complex ecosystems, and with these changes, the dynamic balance between the living components of ecosystems is often disturbed. Experts in climate change, climate policy, emerging infectious diseases and public health discussed the relevant and pressing issues that we as a global community face as the planet's climate is altered.

  • Translational Medicine Initiative

    Macy FoundationThe Translational Medicine Initiative represents a three-year partnership between the New York Academy of Sciences and the Josiah Macy, Jr. Foundation to support the translation of basic science research into clinical applications.

    Learn more at